News | October 10, 2007

62 Percent of Cancer Patients Who Suspected They Had Cancer Not Diagnosed

October 11, 2007 — According to the results of a survey, "Cancer and the Public," 62 percent of the 32 percent of cancer patients who suspected they had cancer, were not diagnosed for three months or more.
In addition, nearly half of the respondents did not feel that their insurance coverage would provide adequate care if diagnosed with a life threatening illness. The total number of respondents to the survey was 4,402, (1,779 males and 2,623 females) representing every state in the U.S.
Among the findings of the survey, which was prepared by The Tower Cancer Research Foundation were:
- 79 percent of respondents said people feared cancer the most.
- Of the 32 percent of cancer victims who suspected they had cancer before being diagnosed, 42 percent did not get diagnosed for six months or longer, 21 percent did not get diagnosed for one year or longer and 9 percent did not get diagnosed for up to two years.

For more information:

Related Content

FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
News | Radiation Dose Management | September 24, 2018
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...